“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a five year holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Alexion Pharmaceuticals Inc. (NASD: ALXN)? Today, we examine the outcome of a five year investment into the stock back in 2014.
| Start date: | 11/18/2014 |
|
|||
| End date: | 11/15/2019 | ||||
| Start price/share: | $192.37 | ||||
| End price/share: | $108.37 | ||||
| Starting shares: | 51.98 | ||||
| Ending shares: | 51.98 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | -43.67% | ||||
| Average annual return: | -10.85% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $5,634.82 | ||||
As we can see, the five year investment result worked out poorly, with an annualized rate of return of -10.85%. This would have turned a $10K investment made 5 years ago into $5,634.82 today (as of 11/15/2019). On a total return basis, that’s a result of -43.67% (something to think about: how might ALXN shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
Here’s one more great investment quote before you go:
“The function of economic forecasting is to make astrology look respectable.” — John Galbraith
